With passion, ExploRNA Therapeutics develops ground-breaking innovations of mRNA as a therapeutic platform, applies those solutions in unique therapeutic programs, and delivers technology, therapeutic platform and therapies to pharmaceutical partners.
ExPLoRNA Therapeutics has raised €758k across 1 funding round from 1 investor, most recently a round in Dec 2022. Based in Warsaw, Poland; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-12-09 | Other |
| €758k |
| Bill & Melinda Gates Foundation Trust |
| View deal → |
